ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
Shardlow A, et al.. Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3. BMJ Open. 2017; http://dx.doi.org/10.1136/bmjopen-2017-016528].
FGF23 Doesn’t Predict Outcomes in Patients with Low-Risk Stage 3 CKD, Study Finds
© 2021 American Society of Nephrology | All Rights Reserved
Powered by: PubFactory
Powered by PubFactory